TRACON Pharmaceuticals Inc. - TCON Net Assets per Single Share

Graphic logo of TRACON Pharmaceuticals (TCON)

Strong patents and strict FDA oversight create significant barriers to entry for competitors. The book value per share curve demonstrates asset resilience, where the -0.66 metric determines this level. A capital-light model featuring an IT platform for research mitigates risks. Meanwhile, oncologists value the TRACON Pharmaceuticals (TCON) brand for its innovative methods of blocking the nutrient supply to malignant tumors.

TRACON (TCON) Equity per Share: for the period 07/04/2022 - 08/04/2024

TCON (traconpharma.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart TRACON|TCON - Average Forecast Price
- market capitalization data:
Market Value TRACON Pharmaceuticals, Inc.|TCON - Business Value
- book capitalization data:
Book Value per Share TRACON Pharmaceuticals|TCON - Accounting Capitalization|Market Value to Book Value Ratio traconpharma.com|TCON - Total Business Assets
- debt and liquidity data:
Total Debt to Capital TRACON Pharmaceuticals|TCON - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio TRACON Pharmaceuticals, Inc.|TCON - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio TRACON Pharmaceuticals, Inc.
Fundamental company valuation:TCON TRACON
Manufactured products of TRACON Pharmaceuticals Inc.

Book value per share measures the volume of a company's net assets available to each shareholder, allowing for an assessment of fundamental capital stability. The current calculated book value per share is -0.66, reflecting a liquidity buffer for TRACON Pharmaceuticals (TCON) amid a lack of revenue and a business valuation dependent on future B2B contracts for the sale of oncology drug rights.

Competitors of TRACON Pharmaceuticals (TCON)

TEM (Tempus AI, Inc.) - Net Assets per Single Share|QGEN: Net Asset Value per Share|Net Assets per Single Share Ionis Pharmaceuticals|repligen.com (RGEN) - Equity per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|SRPT - Book Value per Share|Accounting Value per Share Twist Bioscience, Inc. TWST|TXG: Book Price of a Share|Net Assets per Single Share Intellia NTLA|Stoke Corp (STOK) - Accounting Value of a Share|BLFS (BioLife Solutions, Inc.) - Book Value per Share|Book Value per Share wavelifesciences.com|Book Value per Share MAZE (Maze Therapeutics)|Accounting Value per Share SION (Sionna Therapeutics, Inc.)|PRME: Net Assets per Single Share|Taysha Corp - Net Asset Value per Share|uniQure N.V. (QURE) - Net Assets per Single Share|meiragtx.com (MGTX) - Equity per Share|Accounting Value per Share REGENXBIO RGNX|SLDB (Solid Biosciences Inc) - Accounting Value of a Share|Net Assets per Single Share Ocugen Corp OCGN|Share Book Value PacBio Corp|Benitec Biopharma Inc. (BNTC) - Book Value per Share|Accounting Value of a Share designtx.com (DSGN)|Book Value per Share RCKT (Rocket Pharmaceuticals, Inc.)|4DMT - Book Value per Share|Net Assets per Single Share Lexeo (LXEO)|KRRO: Accounting Value of a Share|EDIT (Editas Medicine, Inc.) - Net Assets per Single Share|silence-therapeutics.com (SLN) - Accounting Value per Share|PRQR (ProQR) - Book Value per Share|Book Value per Share Codexis Bio|Book Value per Share SGMO (Sangamo)|Accounting Value per Share nautilus.bio (NAUT)|MGX: Book Value per Share|DTIL - Net Asset Value per Share|Generation Bio Corp - Accounting Value per Share|Boundless Bio Inc. (BOLD) - Book Value per Share|XCUR - Accounting Value per Share|Imunon (IMNN) - Book Price of a Share|PHIO: Book Value per Share|Net Assets per Share Mustang Bio Corp|Book Value per Share RNAZ (TransCode Therapeutics)|Accounting Value per Share bionanogenomics.com (BNGO)|Book Value per Share APDN (Applied DNA)|bluebird bio, Inc - Book Value per Share|IPA - Net Assets per Single Share|OMGA: Net Assets per Single Share|Singular Genomics - Net Assets per Single Share|Net Assets per Share Regulus Therapeutics, Inc.|Syros (SYRS) - Accounting Value per Share|Book Price of a Share Telesis Bio, Inc|Book Value per Share UBX (Unity Biotechnology)